Skip to main content
Erschienen in: Journal of Bioethical Inquiry 1/2020

17.01.2020 | Symposium: Pharmaceutical Ethics

Pharmaceutical Ethics and Grassroots Activism in the United States: A Social History Perspective

verfasst von: Sharon Batt, Judy Butler, Olivia Shannon, Adriane Fugh-Berman

Erschienen in: Journal of Bioethical Inquiry | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Abstract

Women’s health activists laid the groundwork for passage of the law that created the U.S. Food and Drug Administration in 1906. The pharmaceutical and food industries fought regulatory reforms then and continue to do so now. We examine public health activism in the Progressive Era, the postwar era and the present day. The women’s health movement began in the 1960s, and criticized both the pharmaceutical industry and the medical establishment. In the 1990s, patient advocacy groups began accepting industry funds; thousands of commercially-funded groups now dominate the advocacy landscape. As pharma funding became normalized, concerns arose regarding a) the lack of transparency and public accountability regarding funding, b) the distortion of groups’ agendas, and c) the ability of pharma-funded groups to dominate the discourse and override less well-resourced patient and health advocacy groups. Although industry-funded groups argue that funding allows them to provide useful services, the trade-off in health risks, exorbitant prices and distorted information is far too high. Sincerity is beside the point; patients and the industry have differing interests when it comes to drug safety and efficacy, drug information and drug prices. A growing resistance movement is asserting the values of its activist predecessors and opposing the prevailing culture of pharma-funded advocacy.
Literatur
Zurück zum Zitat Ball, D.E., K. Tisocki, and A. Herxheimer. 2006. Advertising and disclosure of funding on patient organisation websites: A cross-sectional survey. BMC Public Health 6(201). Ball, D.E., K. Tisocki, and A. Herxheimer. 2006. Advertising and disclosure of funding on patient organisation websites: A cross-sectional survey. BMC Public Health 6(201).
Zurück zum Zitat Batt, S. 2017. Health Advocacy, Inc: How pharmaceutical funding changed the breast cancer movement. Vancouver: UBC Press. Batt, S. 2017. Health Advocacy, Inc: How pharmaceutical funding changed the breast cancer movement. Vancouver: UBC Press.
Zurück zum Zitat Best Practices. 2004. Patient advocacy & professional organizations: Building effective relationships. Chapel Hill, NC: Best Practices, LLC. Best Practices. 2004. Patient advocacy & professional organizations: Building effective relationships. Chapel Hill, NC: Best Practices, LLC.
Zurück zum Zitat Boston Women's Health Book Collective, and J. Norsigian. 1970. Women and their bodies: A course. Boston, MA: Boston Women’s Health Collective and New England Free Press. Boston Women's Health Book Collective, and J. Norsigian. 1970. Women and their bodies: A course. Boston, MA: Boston Women’s Health Collective and New England Free Press.
Zurück zum Zitat Breitstein, J. 2002. Partnerships and perspectives. Pharmaceutical Executive 22(1): 68. Breitstein, J. 2002. Partnerships and perspectives. Pharmaceutical Executive 22(1): 68.
Zurück zum Zitat Cox, T.P. 2002. Forging alliances: Advocacy partners, Pharmaceutical Executive. suppl. PR Power: 8–13. Cox, T.P. 2002. Forging alliances: Advocacy partners, Pharmaceutical Executive. suppl. PR Power: 8–13.
Zurück zum Zitat Brenner, B. 2000. Sister support: Women create a breast cancer movement. In Breast cancer: Society shapes an epidemic, edited by A.S. Kasper and S.J. Ferguson, 325–352. New York: St. Martin’s Press.CrossRef Brenner, B. 2000. Sister support: Women create a breast cancer movement. In Breast cancer: Society shapes an epidemic, edited by A.S. Kasper and S.J. Ferguson, 325–352. New York: St. Martin’s Press.CrossRef
Zurück zum Zitat Campbell, M.A./ M.C. Howell. 1973. Why would a girl go into medicine? Medical education in the United States: A guide for women. Old Westbury, NY: Feminist Press. Campbell, M.A./ M.C. Howell. 1973. Why would a girl go into medicine? Medical education in the United States: A guide for women. Old Westbury, NY: Feminist Press.
Zurück zum Zitat Chesler, P. 1972. Women and madness. University of Michigan, MI: Allen Lane. Chesler, P. 1972. Women and madness. University of Michigan, MI: Allen Lane.
Zurück zum Zitat Delaney, M. 2005. AIDS activism and the pharmaceutical industry. In Ethics and the pharmaceutical industry, edited by M.A. Sontoro and T.M. Gorrie, 300–326. Cambridge, UK: Cambridge University Press.CrossRef Delaney, M. 2005. AIDS activism and the pharmaceutical industry. In Ethics and the pharmaceutical industry, edited by M.A. Sontoro and T.M. Gorrie, 300–326. Cambridge, UK: Cambridge University Press.CrossRef
Zurück zum Zitat Epstein, S. 1996. Impure science: AIDS, activism, and the politics of knowledge. Berkeley, CA: University of California Press. Epstein, S. 1996. Impure science: AIDS, activism, and the politics of knowledge. Berkeley, CA: University of California Press.
Zurück zum Zitat Goodwin, L.S. 1999. The pure food, drink and drug crusaders, 1879–1914. Jefferson, N.C.: McFarland. Goodwin, L.S. 1999. The pure food, drink and drug crusaders, 1879–1914. Jefferson, N.C.: McFarland.
Zurück zum Zitat Haire, D. 1972. The cultural warping of childbirth: A special report. Seattle: International Childbirth Education Association. Haire, D. 1972. The cultural warping of childbirth: A special report. Seattle: International Childbirth Education Association.
Zurück zum Zitat Hilts, P.J. 2003. Protecting America's health: The FDA, business and one hundred years of regulation. NY: Knopf. Hilts, P.J. 2003. Protecting America's health: The FDA, business and one hundred years of regulation. NY: Knopf.
Zurück zum Zitat Hoffman, B. 2003. Health care reform and social movements in the United States. American Journal of Public Health 93(1): 75–85.CrossRef Hoffman, B. 2003. Health care reform and social movements in the United States. American Journal of Public Health 93(1): 75–85.CrossRef
Zurück zum Zitat Jacobson, M.F. 2005. Lifting the veil of secrecy from industry funding of nonprofit health organizations. International Journal of Occupational and Environmental Health 11(4): 349–355.CrossRef Jacobson, M.F. 2005. Lifting the veil of secrecy from industry funding of nonprofit health organizations. International Journal of Occupational and Environmental Health 11(4): 349–355.CrossRef
Zurück zum Zitat Li, D.G., S. Singer, and A. Mostaghimi. 2019. Prevalence and disclosure of potential conflicts of interest in dermatology patient advocacy organizations. JAMA Dermatology 155(4):460–464.CrossRef Li, D.G., S. Singer, and A. Mostaghimi. 2019. Prevalence and disclosure of potential conflicts of interest in dermatology patient advocacy organizations. JAMA Dermatology 155(4):460–464.CrossRef
Zurück zum Zitat Marshall, J., and P. Aldhous. 2006. Swallowing the best advice? New Scientist 192(2575): 18–22.CrossRef Marshall, J., and P. Aldhous. 2006. Swallowing the best advice? New Scientist 192(2575): 18–22.CrossRef
Zurück zum Zitat McCoy, M.S., M. Carniol, K. Chockley, J.W. Urwin, E.J. Emanuel, and H. Schmidt. 2017. Conflicts of interest for patient-advocacy organizations. New England Journal of Medicine 376(9): 880–885.CrossRef McCoy, M.S., M. Carniol, K. Chockley, J.W. Urwin, E.J. Emanuel, and H. Schmidt. 2017. Conflicts of interest for patient-advocacy organizations. New England Journal of Medicine 376(9): 880–885.CrossRef
Zurück zum Zitat McCoy, M.S. 2018. Industry support of patient advocacy organizations: The case for an extension of the Sunshine Act provisions of the Affordable Care Act. American Journal of Public Health 108(8): 1026–1030CrossRef McCoy, M.S. 2018. Industry support of patient advocacy organizations: The case for an extension of the Sunshine Act provisions of the Affordable Care Act. American Journal of Public Health 108(8): 1026–1030CrossRef
Zurück zum Zitat Mills, F. 2000. Patient groups and the global pharmaceutical industry: The growing importance of working directly with the consumer. London: Urch Publishing. Mills, F. 2000. Patient groups and the global pharmaceutical industry: The growing importance of working directly with the consumer. London: Urch Publishing.
Zurück zum Zitat Nichols, F.H. 2000. History of the women’s health movement in the 20th Century. Journal of Obstetric, Gynecologic & Neonatal Nursing 29(1): 56–64.CrossRef Nichols, F.H. 2000. History of the women’s health movement in the 20th Century. Journal of Obstetric, Gynecologic & Neonatal Nursing 29(1): 56–64.CrossRef
Zurück zum Zitat Pearson, C., and E. Michaud. 2002. The truth about hormone replacement therapy: How to break free from the medical myths of menopause. Roseville, CA: Prima Pub. Pearson, C., and E. Michaud. 2002. The truth about hormone replacement therapy: How to break free from the medical myths of menopause. Roseville, CA: Prima Pub.
Zurück zum Zitat Rose, S.L. 2013. Patient advocacy organizations: Institutional conflicts of interest, trust, and trustworthiness. The Journal of Law, Medicine & Ethics 41(3): 680–687.CrossRef Rose, S.L. 2013. Patient advocacy organizations: Institutional conflicts of interest, trust, and trustworthiness. The Journal of Law, Medicine & Ethics 41(3): 680–687.CrossRef
Zurück zum Zitat Rose, S.L., J. Highland, M.T. Karafa, and S. Joffe. 2017. Patient advocacy organizations, industry funding, and conflicts of interest. JAMA Internal Medicine 177(3): 344.CrossRef Rose, S.L., J. Highland, M.T. Karafa, and S. Joffe. 2017. Patient advocacy organizations, industry funding, and conflicts of interest. JAMA Internal Medicine 177(3): 344.CrossRef
Zurück zum Zitat Rothman, S.M., V.H. Raveis, A. Friedman, and D.J. Rothman. 2011. Health advocacy organizations and the pharmaceutical industry: An analysis of disclosure practices. American Journal of Public Health 101(4): 602–609.CrossRef Rothman, S.M., V.H. Raveis, A. Friedman, and D.J. Rothman. 2011. Health advocacy organizations and the pharmaceutical industry: An analysis of disclosure practices. American Journal of Public Health 101(4): 602–609.CrossRef
Zurück zum Zitat Ruzek, S.B., and J. Becker. 1999. The women's health movement in the United States: From grass-roots activism to professional agendas. Journal of The American Medical Women's Association 54(1): 4–8. Ruzek, S.B., and J. Becker. 1999. The women's health movement in the United States: From grass-roots activism to professional agendas. Journal of The American Medical Women's Association 54(1): 4–8.
Zurück zum Zitat Seaman, B. 1969. The doctors’ case against the pill. Reprint, Alameda, CA: Hunter House, 1995. Seaman, B. 1969. The doctors’ case against the pill. Reprint, Alameda, CA: Hunter House, 1995.
Metadaten
Titel
Pharmaceutical Ethics and Grassroots Activism in the United States: A Social History Perspective
verfasst von
Sharon Batt
Judy Butler
Olivia Shannon
Adriane Fugh-Berman
Publikationsdatum
17.01.2020
Verlag
Springer Singapore
Erschienen in
Journal of Bioethical Inquiry / Ausgabe 1/2020
Print ISSN: 1176-7529
Elektronische ISSN: 1872-4353
DOI
https://doi.org/10.1007/s11673-019-09956-8

Weitere Artikel der Ausgabe 1/2020

Journal of Bioethical Inquiry 1/2020 Zur Ausgabe

Editorial

Cui Bono?